Clinical trials: Orbital Pseudotumor
Orbital Pseudotumor
Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation
A multicenter randomised double-arm clinical trial, to compare safety and efficacy of oral versus intralesional injection of steroid in a group of patients suffering from idiopathic orbital inflammation is designed.
- Trial name
- NCT03958344
- Testing
- Prednisolone, Triamcinolone + Betamethason
- Where
- Iran
- Volunteers
- 120 people
- Sponsor
- Iran University of Medical Sciences
Orbital Ischemic Syndrome, Orbital Pseudotumor
Survey of Patients With Idiopathic Orbital Inflammation Syndrome
The purpose of this study is to characterise the clinical features, histopathology and the treatment outcomes of patients with idiopathic orbital inflammation syndrome.
- Trial name
- SIOI (NCT01443000)
- Where
- France
- Volunteers
- 87 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Orbital Tumor, Orbital Pseudotumor
MRI and Orbital Tumours (MEDORT)
Orbital masses develop at the expense of the orbital structures lacrimal glands, oculomotor muscles, optic nerve, meningeal spaces, peripheral nerves, bone wall, orbital fat, lymphoid structures or vascular structures.
- Trial name
- MEDORT (NCT02401906)
- Testing
- MRI
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
Retroperitoneal Fibrosis, Autoimmune Pancreatitis
Rituximab in IgG4-RD: A Phase 1-2 Trial
The primary objective of this study is to evaluate the safety and effectiveness of rituximab in IgG4-RD.
- Conditions
- Retroperitoneal Fibrosis, Autoimmune Pancreatitis, Sialadenitis, Pseudotumor
- Trial name
- NCT01584388
- Testing
- Rituximab
- Volunteers
- 30 people
- Sponsor
- Massachusetts General Hospital